Navigation Links
For the First Time, at EuroPCR, InspireMD Will Provide a Sneak Preview of the Next Generation MGuard Prime(R), a State of the Art Net Protective Cobalt Chromium Stent System
Date:5/26/2010

of the INSPIRE trial, and long awaited 1 year clinical FU with 6 month angiographic results.

The INSPIRE Trial from Sao-Paulo, Brazil is a 30 patients' study that enrolled SVG and native coronary patients. Acute results as well as interim results have previously been presented by Dr. A. Abizaid, the study's primary investigator.

The international iMOS registry has crossed the 200 patients' milestone. The registry will enroll 1000 'real world' MGuard(TM) patients in Europe, Asia and South America. Data from the registry, an unselected heterogeneous population, will be used to support data from other clinical studies. Interim data analysis will be presented by Prof. GB. Danzi, from the iMOS steering committee, at InspireMD's evening symposium this evening.

About MGuard(TM) Coronary

MGuard(TM) presents a novel combination of a coronary stent merged with an embolic protection. The embolic protection is comprised of an ultra-thin polymer mesh sleeve that wraps the stent. The protective sleeve is composed of a micron-level-fiber which is knit in order to ensure flexibility while retaining the strength characteristics of the fiber material. The sleeve is designed to expand seamlessly when the stent is deployed, without affecting the structural integrity of the stent. The MGuard(TM) coronary stent provides permanent embolic protection, without complicating deliverability. Reduced injury to the vessel as a result of diffused stent pressure is a benefit of the sleeve which may lead to lower risk of restenosis. MGuard(TM) is CE Mark approved.

The MGuard(TM) Coronary's innovative concept has enjoyed an enthusiastic welcome from leading
'/>"/>

SOURCE InspireMD
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Hanley Center Acquires the East Coasts First SPECT Scanner to Treat Addiction
2. First Coronary Stent on Drug Eluting Balloon Implanted
3. ExpertRECALL Awards First Scholarships for Product-Safety Education
4. China Yongxin Pharmaceuticals Reports First Quarter 2010 Financial Results
5. Physicians Cite Positive First Clinical Experience with Volcanos Eagle Eye® Platinum Digital IVUS Catheter
6. In a World First, Asda Announces Not for Profit Price on All Cancer Treatment Drugs
7. Concord Medical to Report First Quarter 2010 Financial Results on Thursday, May 27, 2010
8. Heska Announces First Installation of New Blood Gas & Electrolyte Analyzer
9. WellPoint Is First Health Benefits Company to Release CER Guidelines for Use in Evaluating Pharmaceuticals
10. China Ruitai International Holdings Co., Ltd. Reports Results for the First Quarter 2010
11. Medical Product Outsourcing Magazine Announces the First Annual CardioTec Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... the leading health care supply chain expertise, analytics and ... national contracts that expand its portfolio to provide hospital ... These include manufacturer product and service agreements, as well ... IT consulting support. New Novation agreements ...
(Date:1/15/2014)... January 15, 2014 BreedIT Corp (OTC: ... worldwide distributor of highly sophisticated agro-breeding solutions for plant ... 2014, the Company,s board of directors appointed chemistry and ... its new member of the board. From ...
(Date:1/15/2014)... , Jan. 15, 2014  Echo Therapeutics, Inc. (Nasdaq: ... its Symphony® CGM System as a non-invasive, wireless continuous ... Doman , Executive Chairman and Interim CEO of Echo ... Tenth Annual Equity Conference. Mr. Doman ...
Breaking Medicine Technology:New Novation Information Technology VAR Contracts Offer Significant Savings to Hospitals 2BreedIT (OTC: BRDT) Appoints Chemistry and Pharmaceutical Industry Expert Dr. Ben-Zion Weiner to Its Board of Directors 2BreedIT (OTC: BRDT) Appoints Chemistry and Pharmaceutical Industry Expert Dr. Ben-Zion Weiner to Its Board of Directors 3Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 2Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 3
... Corporation has announced the release of its next-generation slide scanners, ... of the original series, the NanoZoomer 2.0 converts a 20 ... a 1.9-gigapixel color image in as little as 1 minute ... on a computer monitor, shared across computer networks, used for ...
... , CRANBURY, N.J., Oct. 7 Cornerstone Pharmaceuticals, Inc., ... research scientist Robert A. Weinberg, Ph.D., a founding member ... Professor of Biology at MIT, has joined the company,s ... discoveries of the first human oncogene (the ras ...
Cached Medicine Technology:New 'Virtual Microscope' System from Hamamatsu Offers Faster Acquisition of High-Resolution Slide Scans 2Cornerstone Pharmaceuticals Adds Acclaimed Cancer Research Pioneer Robert A. Weinberg, Ph.D. to Its Scientific Advisory Board 2Cornerstone Pharmaceuticals Adds Acclaimed Cancer Research Pioneer Robert A. Weinberg, Ph.D. to Its Scientific Advisory Board 3
(Date:4/24/2014)... the first flu pandemic in the 21st century. The ... than 50 people in the country. Since 2011 the ... seasons). , Infections with influenza pH1N1 virus vary ... has recommended Tamiflu for treatment of patients with severe ... that it targets viral proteins which mutate quickly and ...
(Date:4/23/2014)... donors was safe and effective in treating patients ... difficile , according to a new pilot study ... available online. Known as fecal microbiota transplantation, the ... colonoscope or a nasogastric tube. The findings suggest ... readily available to patients. , A growing concern, ...
(Date:4/23/2014)... Spokane have developed a new way to detect ... the wheel. , Their recently patented technology is ... in drowsy driversand offers an affordable and more ... detection systems. , Van Dongen"Video-based systems that use ... out of its lane are cumbersome and expensive," ...
(Date:4/23/2014)... American Society for Radiation Oncology (ASTRO) has issued ... Therapy for Endometrial Cancer: An ASTRO Evidence-Based Guideline," ... in the treatment of endometrial cancer. The guideline,s ... issue of Practical Radiation Oncology (PRO), ... full-length guideline is available as an open-access article ...
(Date:4/23/2014)... University researchers have identified an important enzyme pathway that ... too few chromosomes, a condition that has been directly ... associate professor of biochemistry, found that near the end ... enzyme that ensures any breaks in DNA are fully ... genome to daughter cells. This process helps safeguard against ...
Breaking Medicine News(10 mins):Health News:Pilot study suggests ways to widen access to fecal transplants for C. diff infections 2Health News:WSU innovation improves drowsy driver detection 2Health News:ASTRO issues guideline on the role of postoperative radiation therapy for endometrial cancer 2Health News:ASTRO issues guideline on the role of postoperative radiation therapy for endometrial cancer 3Health News:Study identifies enzymes that help fix cancer-causing DNA defects 2
... , , LA JOLLA, Calif., July ... of TLC(R) Dark Mocha Almond Chewy Granola Bar as the latest ... This new granola bar combines crunchy roasted almonds with rich dark chocolate ... , (Logo: http://www.newscom.com/cgi-bin/prnh/20090331/LA91619LOGO ) , , ...
... , NEWARK, Calif., July 21 Novasys Medical, ... urinary incontinence, announced today that it has received $18.95 million in ... financing. The Company received the first tranche of the Series D ... investors ThreeArch Partners and Skyline Ventures. All three participated in the ...
... , , , ... 21 In an unprecedented and historic show of unity, advocates for ... G-8 countries with reneging on their commitments to health by chronically underfunding ... and health systems strengthening across the globe. , ...
... ... design with antibacterial effectiveness. , ... Portland, OR (Vocus) July 21, 2009 -- HemCon Medical Technologies, Inc. ... a next generation, z-folded hemostatic chitosan dressing, designed for battlefield and acute care use ...
... , LAS VEGAS, July 21 ... its subsidiary, Disability Access Corporation (Pink Sheets: DBYC), its wholly ... $245,000 contract with Tuolumne Joint Powers Authority to provide inspection ... exceed $120,000) with the Office of the Independent Monitor for ...
... , , MADISON, N.J., July ... world,s leading provider of diagnostic testing, information and services, announced that ... operations rose to $188 million, or $1.00 per diluted share, from ... of 2008. These results include a previously disclosed benefit associated with ...
Cached Medicine News:Health News:Kashi Company Introduces TLC(R) Dark Mocha Almond Chewy Bar 2Health News:Novasys Medical Receives $18.95 Million in Second Tranche of Series D Financing 2Health News:Advocates for Health Millennium Development Goals Unite to Demand World Leaders Honor Funding Commitments 2Health News:Advocates for Health Millennium Development Goals Unite to Demand World Leaders Honor Funding Commitments 3Health News:Advocates for Health Millennium Development Goals Unite to Demand World Leaders Honor Funding Commitments 4Health News:Advocates for Health Millennium Development Goals Unite to Demand World Leaders Honor Funding Commitments 5Health News:Advocates for Health Millennium Development Goals Unite to Demand World Leaders Honor Funding Commitments 6Health News:Advocates for Health Millennium Development Goals Unite to Demand World Leaders Honor Funding Commitments 7Health News:Advocates for Health Millennium Development Goals Unite to Demand World Leaders Honor Funding Commitments 8Health News:Next-Generation Hemostatic Dressing Available for Military Emergencies 2Health News:Next-Generation Hemostatic Dressing Available for Military Emergencies 3Health News:PTS, Inc. Subsidiary Disability Access Corporation Announces $535,000 in New Contracts and Inspection Orders for July 2009 2Health News:Quest Diagnostics Reports Strong Performance in Second Quarter 2009 2Health News:Quest Diagnostics Reports Strong Performance in Second Quarter 2009 3Health News:Quest Diagnostics Reports Strong Performance in Second Quarter 2009 4Health News:Quest Diagnostics Reports Strong Performance in Second Quarter 2009 5Health News:Quest Diagnostics Reports Strong Performance in Second Quarter 2009 6Health News:Quest Diagnostics Reports Strong Performance in Second Quarter 2009 7Health News:Quest Diagnostics Reports Strong Performance in Second Quarter 2009 8Health News:Quest Diagnostics Reports Strong Performance in Second Quarter 2009 9Health News:Quest Diagnostics Reports Strong Performance in Second Quarter 2009 10Health News:Quest Diagnostics Reports Strong Performance in Second Quarter 2009 11Health News:Quest Diagnostics Reports Strong Performance in Second Quarter 2009 12Health News:Quest Diagnostics Reports Strong Performance in Second Quarter 2009 13Health News:Quest Diagnostics Reports Strong Performance in Second Quarter 2009 14
Plastic micro-hematocrit capillary tubes from Globe Scientific Inc. are designed for use in 75 mm (3 inches) hematocrit centrifuges and come with many features....
Hemato-clad Hematocrit Tubes combine the precision of glass with the safety provided by a Mylar® overwrap. Now you can give your laboratory staff safety with no compromise in accuracy....
... Vivid 3 system is designed to address ... performance, and offer an even wider range ... the OR. From color flow imaging with ... new Vivid 3 offers a wealth of ...
... Volcano's new VH IVUS technology ... allow simplified interpretation of ultrasound images ... composition of each patient's atherosclerotic plaques. ... plaque component types: fibrous, fibro-fatty, dense ...
Medicine Products: